Home
Joshua T. Brumm, CEO & President: Dyne Therapeutics DYN Sell · Filed 24/03/01
Trade details
- Type
- Insider sale
- Amount
- $2,165,650.7
- Shares · price
- 74,090 sh · $29.23 a share
- Held after
- 564,885 sh
- Trade date
- 24/03/01
- Filed
- 24/03/01
- Days to filing
- 0 days
Sold 11.6% of holdings
- Share of holding sold
- 11.6%
Dyne Therapeutics trades, last 26 weeks
What else happened in Dyne Therapeutics around then
Filed or reported within 30 days of the trade day · 24/01/31~24/03/31Joshua T. Brumm's recent trades
- Joshua T. Brumm
Planned sale10b5-1 planCrescent Biopharma
Planned sale10b5-1 planCrescent Biopharma
CBIO
$154.8K
9,013 sh
$154.8K
Filed 09/17
Traded 09/18
- Joshua T. Brumm
Planned sale10b5-1 planCrescent Biopharma
Planned sale10b5-1 planCrescent Biopharma
CBIO
$33.3K
1,771 sh
$33.3K
Filed 09/16
Traded 09/16
- Joshua T. Brumm
Sell10b5-1 planCrescent Biopharma
Sell10b5-1 planCrescent Biopharma
CBIO
$761.1K
42,305 sh
$761.1K
Filed 06/23
Traded 06/22
- Joshua T. Brumm
Sell10b5-1 planDyne Therapeutics
Sell10b5-1 planDyne Therapeutics
DYN
$5.1M
202,238 sh
$5.1M
Filed 24/03/12
Traded 24/03/08
- Joshua T. Brumm
Sell10b5-1 planDyne Therapeutics
Sell10b5-1 planDyne Therapeutics
DYN
$4.3M
160,670 sh
$4.3M
Filed 24/03/12
Traded 24/03/08
